Home/Filings/4/0000950170-24-069929
4//SEC Filing

Powell Lynne 4

Accession 0000950170-24-069929

CIK 0001580063other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:33 PM ET

Size

7.3 KB

Accession

0000950170-24-069929

Insider Transaction Report

Form 4
Period: 2024-06-05
Powell Lynne
Director
Transactions
  • Award

    Common Stock

    2024-06-05+12,50030,746 total
  • Award

    Stock Option (Right to Buy)

    2024-06-05+12,50012,500 total
    Exercise: $0.70Exp: 2034-06-05Common Stock (12,500 underlying)
Footnotes (2)
  • [F1]Represents 12,500 restricted stock units, which vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
  • [F2]This option represents the right to purchase 12,500 shares of the Issuer's common stock, and vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file

Issuer

BIORA THERAPEUTICS, INC.

CIK 0001580063

Entity typeother

Related Parties

1
  • filerCIK 0001631667

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:33 PM ET
Size
7.3 KB